News

Deal Announcements

Cellectar Collects $13 Million For Clinical Trials

Wednesday, January 9, 2008 5:37:00 AM PDT | VentureDeal Staff
MADISON, WI -- Biotechnology company Cellectar, LLC said that it has raised $13 million in new venture capital investment.

Cellectar designs drugs to "find, treat and follow" cancerous malignancies through the delivery of radio-pharmaceuticals in a unique way.

Investors were led by Venture Investors, and included Advantage Capital and other international investors.  The company said it will use the funds to execute phase 1 trials for its lead candidate, CLR1404.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1